<DOC>
	<DOCNO>NCT02559284</DOCNO>
	<brief_summary>The main objective study compare effect RESPIMER® NetiFlow® solution device versus saline solution ( 0.9 % NaCl ) , standard treatment , use RESPIMER® NetiFlow® device , use postoperative care , context ethmoid sinus surgery , 14 day post-surgery .</brief_summary>
	<brief_title>RESPIMER® Netiflow® vs. Saline Solutions During Nasal Irrigation Following Bilateral Ethmoidectomy ( Nasal Polyposis )</brief_title>
	<detailed_description>This comparative study two postoperative treatment follow ethmoid sinus surgery . The purpose study compare effect RESPIMER® NetiFlow® solution nasal tissue repair versus saline solution ( 0.9 % NaCl ) , standard treatment . The type surgery select study total endoscopic ethmoidectomy . This frequently use standard surgery require nasal cleanse average 28 day . This process allow regeneration nasal epithelial lining wound ( area expose bone ) , well heal swell scar due surgery . The follow last 28 day 4 visit ( D7 , D14 , D21 D28 ) . RESPIMER® NetiFlow® : device class I , CE mark , indication sinus postoperative care .</detailed_description>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Males females 18 65 year age Subject need sinus surgery bilateral total ethmoidectomy use endoscopic endonasal approach whose pathology result : Sinonasal polyposis alone Sinonasal polyposis associate asthma / intolerance NSAIDs Free inform write consent Member beneficiary social security program Oral corticosteroid treatment since less 2 month Premenopausal woman use effective contraception ( oral intrauterine device ) Pregnant nurse woman Uncontrolled diabetes ( treat stabilize treatment ) HIVpositive status Autoimmune diseases affect nose and/or sinus , immune dysfunction ( Wegener 's granulomatosis , ChurgStrauss syndrome , Common Variable Immunodeficiency , sarcoidosis ... ) , malignant disease ( unclear histology ) All contraindication RESPIMER® NetiFlow® All diseases result difficulty cough swallow Ongoing past radiation treatment head neck Ongoing recent chemotherapy ( within threemonth period ) Subjects use anticoagulant Subjects take part another study include exclusion period coincide runin period study Subjects place judicial protection Subjects suffer severe physical psychological problem whose condition , accord investigator , affect compliance study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Saline Solution , Isotonic / Administration &amp; dosage</keyword>
	<keyword>Therapeutic Irrigation / method</keyword>
	<keyword>Postoperative Care / method</keyword>
	<keyword>Quality life</keyword>
</DOC>